Third, our results showed that non-severe patients with COVID-19 who had a level of hs-cTnI ≥ 5 ng/L had significantly higher levels of CRP and lung involvement and lower levels of SpO2 and lymphocyte count compared with those with hs-cTnI under 5 ng/L. This evidence concerns the gene TNNI3 and COVID-19.